A Smartphone Application for a Self-directed Upper Limb Therapy After Stroke

September 3, 2025 updated by: Tan Tock Seng Hospital

Feasibility and Effectiveness of AI-powered Interactive Smartphone Application for a Self-directed Upper Limb Therapy Implementation After Stroke

The aim of study is to investigate a newly developed AI smartphone application's feasibility, usefulness in improving users' experience, effect on adherence, UL use and recovery after stroke. The study is a prospective randomized controlled trial (RCT) to compare the implementation of AMPLIFY, a self-directed UL programme for people with stroke in two modes of delivery- hardcopy manual versus the mobile application. Eighty people with stroke within 4 weeks of stroke will be randomly allocated to either the experimental group (smartphone app) or control group (hardcopy manual) to undergone four weeks of AMPLIFY program. To compare the clinical effects of delivery AMPLIFY program via smartphone app versus hardcopy manual, assessments will be done at three time points- pre-intervention, post-intervention and three months post-intervention.

Study Overview

Status

Completed

Conditions

Detailed Description

Background To intensify practice to influence neuroplasticity to optimize UL recovery after stroke, it is important to empower people with stroke to perform self-directed UL therapy outside therapy. However, it has been found that increasing UL practice is often challenging with high level of inactivity found in people with stroke during rehabilitation. Traditionally, self-directed program has been delivered via hard copy manuals. Hardcopy manuals are often cumbersome and difficult to retrieve and handle, especially for those with moderate/severe UL impairment. Hence a more accessible format of exercise/activities instructions is needed. There is lack of reminders for people with stroke to keep up to prescribed exercise regime. This may affect adherence as some may not remember the prescribed practice sessions. Without immediate feedback of UL movement performed during self-practice, people with stroke may continue with compensatory movement performance without correction. This may in turns hinder UL recovery.

The aim of this study is to overcome these challenges by developing an AI-powered interactive smartphone application called AMPLIFY app that enables prescription and progression of exercises/functional activities, while offering immediate feedback on UL movement performed, real-time logging and monitoring of adherence through virtual platform. The inherent interactive nature of app offers features to engage and remind people with stroke to use their paretic UL. This app offers remote monitoring and supervision by therapists without need for actual therapists' physical presence. As the AMPLIFY app is a newly developed AI-powered interactive smartphone application, it is important to investigate the app's feasibility, usefulness in improving users' experience, effect on adherence, UL use, recovery and cost-effectiveness.

Aim:

To Investigate:

  1. Feasibility of AMPLIFY app in completing self-directed UL therapy programme
  2. Usefulness of AMPLIFY app in improving the users' experience in self-directed UL therapy programme performance
  3. Effectiveness of AMPLIFY app in increasing adherence in self-directed UL therapy programme performance
  4. Effectiveness of AMPLIFY app in increasing UL use, confidence and improving recovery after stroke
  5. Cost-effectiveness of AMPLIFY app in reducing the need for clinical review in self-directed UL therapy programme performance

Methods:

The study is a prospective randomized controlled trial (RCT) to compare the implementation of AMPLIFY programme in two modes of delivery- smartphone app versus hardcopy manuals to investigate the aims mentioned above.

People with stroke who fit into the inclusion and exclusion criteria will be invited to participate in the study via informed consent by the research assistant (RA)/ study team members. Once the informed consent has been given by the participants, the participants will undergo the pre-intervention assessment. After the pre-intervention assessment, the participants will be randomised either to the experimental group (AMPLIFY programme via the smartphone app) or control group (AMPLIFY programme via the hardcopy manuals). The intervention of experimental and control arms are described below. Both groups essentially undergo the same AMPLIFY programme but via different modes. Time points of assessment: pre-intervention, post-intervention and post-3months intervention assessments.

Experimental arm Assigned intervention The AMPLIFY Programme will be delivered via smartphone application with two levels. Level 1 is catered for people with stroke with Action Research Arm Test (ARAT) score <34, while Level 2 is catered for people with stroke with ARAT score >=34. Level 1 consists of six warm up exercises, six strengthening exercises and ten functional activities. Level 2 consists of three warm up exercises, four strengthening exercises, nine hand coordination and dexterity exercises, and ten functional activities. Five to six exercises (including at least one functional activity) will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed the exercises/functional activities three sessions per day (i.e. morning, afternoon, evening) and for six days per week. In addition, the stroke participants are to use their paretic UL to perform the functional activities prescribed to them whenever needed throughout the day. The AMPLIFY programme will last for four weeks. If the stroke participants are discharged before the AMPLIFY programme ends, the participants will continue with the programme at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the experimental group will be as follows: Week1 (2x); Week2 (1x); Week3 (x0); Week4 (x1).

Control arm Assigned intervention The AMPLIFY Programme consists of two booklets (Booklet 1 and Booklet 2). Booklet 1 is catered for people with stroke with ARAT score <34, while Booklet 2 is catered for people with stroke with ARAT score >=34. Booklet 1 consists of six warm up exercises, six strengthening exercises and ten functional activities. Booklet 2 consists of three warm up exercises, four strengthening exercises, nine hand coordination and dexterity exercises, and ten functional activities. Five to six exercises (including at least one functional activity) will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed the exercises/functional activities three sessions per day (i.e. morning, afternoon, evening) and for six days per week. In addition, the stroke participants are to use their paretic UL to perform the functional activities prescribed to them whenever needed throughout the day. The AMPLIFY programme will last for four weeks. If the stroke participants are discharged before the AMPLIFY programme ends, the participants will continue with the programme at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the control group will be as follows: Week1 (3x); Week2 (2x); Week3 (x1); Week4 (x1).

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Singapore
      • Singapore, Singapore, Singapore, 307382
        • Lay Fong Chin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosis of stroke (confirmed by CT/MRI scans)
  • ≤four weeks post-stroke
  • Montreal Cognitive Assessment (MOCA)>=21
  • Finger extension Medical Research Council (MRC) >=1
  • Fugl Meyer Upper Limb score <60 or NIHSS Motor Arm section score>=2
  • Potential discharge to home (able to do tele-rehabilitation for review)

Exclusion Criteria:

  • Bilateral stroke
  • Montreal Cognitive Assessment (MOCA)<21
  • Paretic upper limb numeric pain rating scale (NPRS)>5
  • Reduced paretic upper limb use prior to stroke episode (e.g. frozen shoulder, fracture, etc)
  • Reduced paretic upper limb use due to orthopaedic problems such as fracture in existing stroke episode
  • Medically unstable
  • Neglect as ascertained by treatment team
  • Severe behavioural disturbance or agitation or epilepsy or untreated depression or psychiatric conditions
  • Pregnancy or lactation states

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Smartphone Application
AMPLIFY Programme delivered via smartphone application with 2 levels. Level 1 is catered for people with stroke with ARAT score <34, while Level 2 is catered for people with stroke with ARAT score >=34. Five to 6 exercises will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed exercises 3 sessions per day for 6 days per week. Stroke participants are to use paretic UL to perform functional activities prescribed whenever needed throughout the day. AMPLIFY programme will last for 4 weeks. If the stroke participants are discharged before 4 weeks, the participants will continue at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the experimental group will be: Week1 (2x); Week2 (1x); Week3 (x0); Week4 (x1).
AMPLIFY Smartphone Application enables prescription and progression of exercises/functional activities, while offering immediate feedback on upper limb movement performed, real-time logging and monitoring of adherence through virtual platform
Active Comparator: Hardcopy Manual
AMPLIFY Programme will be delivered via hardcopy manual. AMPLIFY Programme consists of two booklets (Booklet 1 and Booklet 2). Booklet 1 is catered for people with stroke with ARAT score <34, while Booklet 2 is catered for people with stroke with ARAT score >=34. Five to 6 exercises will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed the exercises 3 sessions per day for 6 days per week. Stroke participants are to use paretic UL to perform functional activities prescribed whenever needed throughout the day. AMPLIFY programme will last for 4 weeks. If stroke participants are discharged before AMPLIFY programme ends, the participants will continue at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the control group will be as follows: Week1 (3x); Week2 (2x); Week3 (x1); Week4 (x1).
Hardcopy Manual

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Action Research Arm Test
Time Frame: Change from pre-intervention to immediate post-intervention
Change in Action Research Arm Test (minimum score 0 - maximum score 57; the higher the score the better the upper limb performance)
Change from pre-intervention to immediate post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility - Number of drop-out
Time Frame: Throughout the 4 weeks of intervention
Number of drop-out from AMPLIFY Programme
Throughout the 4 weeks of intervention
Feasibility- Number of adverse events related to AMPLIFY Programme
Time Frame: Throughout the 4 weeks of intervention
Number of adverse events related to intervention
Throughout the 4 weeks of intervention
AMPLIFY Programme Adherence
Time Frame: Throughout the 4 weeks of intervention
Percentage of adherence to the prescribed AMPLIFY Programme
Throughout the 4 weeks of intervention
Number of upper limb repetitions performed in AMPLIFY Programme
Time Frame: Throughout the 4 weeks of intervention
Number of upper limb repetitions performed in AMPLIFY Programme
Throughout the 4 weeks of intervention
Number of Clinical Reviews in AMPLIFY Programme
Time Frame: Throughout the 4 weeks of intervention
Number of Clinical Reviews in AMPLIFY Programme
Throughout the 4 weeks of intervention
Change in Action Research Arm Test
Time Frame: Change from immediate post-intervention to 3 month post-intervention
Change in Action Research Arm Test (minimum score 0 - maximum score 57; the higher the score the better the upper limb performance)
Change from immediate post-intervention to 3 month post-intervention
Change in Upper Limb Self-Efficacy Test
Time Frame: Change from pre-intervention to immediate post-intervention
Change in Upper Limb Self-Efficacy Test (minimum score 0 - maximum score 200; the higher the score the higher the level of self-efficacy in upper limb use)
Change from pre-intervention to immediate post-intervention
Change in Upper Limb Self-Efficacy Test
Time Frame: Change from immediate post-intervention to 3 month post-intervention
Change in Upper Limb Self-Efficacy Test (minimum score 0 - maximum score 200; the higher the score the higher the level of self-efficacy in upper limb use)
Change from immediate post-intervention to 3 month post-intervention
Change in Rating of Everyday Arm-use in the Community and Home
Time Frame: Change from pre-intervention to immediate post-intervention
Change in Rating of Everyday Arm-use in the Community and Home (minimum score 0 -maximum score 5; the higher the score the higher the level of upper limb use)
Change from pre-intervention to immediate post-intervention
Change in Rating of Everyday Arm-use in the Community and Home
Time Frame: Change from immediate post-intervention to 3 month post-intervention
Change in Rating of Everyday Arm-use in the Community and Home (minimum score 0 -maximum score 5; the higher the score the higher the level of upper limb use)
Change from immediate post-intervention to 3 month post-intervention
Change in Stroke Rehabilitation Motivation Scale
Time Frame: Change from pre-intervention to immediate post-intervention
Change in Stroke Rehabilitation Motivation Scale (minimum score 28 - maximum score 140; the higher the score the higher the level of motivation)
Change from pre-intervention to immediate post-intervention
Change in Stroke Rehabilitation Motivation Scale (SRMS)
Time Frame: Change from immediate post-intervention to 3 month post-intervention
Change in Stroke Rehabilitation Motivation Scale (minimum score 28 - maximum score 140; the higher the score the higher the level of motivation)
Change from immediate post-intervention to 3 month post-intervention
Change in upper limb pain visual analogue scale
Time Frame: Change from pre-intervention to immediate post-intervention
Change in upper limb pain visual analogue scale (minimum score 0 - maximum score 10; the higher the score the higher the level of upper limb pain)
Change from pre-intervention to immediate post-intervention
Change in upper limb pain visual analogue scale
Time Frame: Change from immediate post-intervention to 3 month post-intervention
Change in upper limb pain visual analogue scale (minimum score 0 - maximum score 10; the higher the score the higher the level of upper limb pain)
Change from immediate post-intervention to 3 month post-intervention
Change in upper limb Modified Ashworth Scale
Time Frame: Change from pre-intervention to immediate post-intervention
Change in upper limb Modified Ashworth Scale (minimum score 0 - maximum score 4; the higher the score the higher the level of upper limb resistance to passive movement)
Change from pre-intervention to immediate post-intervention
Change in upper limb Modified Ashworth Scale
Time Frame: Change from immediate post-intervention to 3 month post-intervention
Change in upper limb Modified Ashworth Scale (minimum score 0 - maximum score 4; the higher the score the higher the level of upper limb resistance to passive movement)
Change from immediate post-intervention to 3 month post-intervention
User Experience Survey
Time Frame: End of 4 weeks intervention
Feedback on user experience on hardcopy manual / smartphone application (minimum score 0 - maximum score 40; the higher the score the higher the ease and satisfaction to the use of the hardcopy manual / smartphone application)
End of 4 weeks intervention
Affinity for Technology Interaction Scale
Time Frame: Pre-intervention
Affinity for Technology Interaction Scale (minimum score 1 - maximum score 6; the higher the score the higher the affinity to technology)
Pre-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 11, 2024

Primary Completion (Actual)

March 31, 2025

Study Completion (Actual)

March 31, 2025

Study Registration Dates

First Submitted

December 19, 2023

First Submitted That Met QC Criteria

January 3, 2024

First Posted (Actual)

January 5, 2024

Study Record Updates

Last Update Posted (Estimated)

September 10, 2025

Last Update Submitted That Met QC Criteria

September 3, 2025

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on AMPLIFY Smartphone Application

Subscribe